Search

Author/Creator Sonke, Gabe S

1. Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients. (8th June 2021)

Authors:
Dackus, Gwen M H E; Jóźwiak, Katarzyna; Sonke, Gabe S; van der Wall, Elsken; van Diest, Paul J; Siesling, Sabine; Hauptmann, Michael; Linn, Sabine C
Journal:
Journal of the National Cancer Institute
Issue:
Volume 113:Number 11(2021)
Page Start:
1506
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Characterization of Oligometastatic Disease in a Real-World Nationwide Cohort of 3447 Patients With de Novo Metastatic Breast Cancer. Issue 3 (4th February 2021)

Authors:
Steenbruggen, Tessa G; Schaapveld, Michael; Horlings, Hugo M; Sanders, Joyce; Hogewoning, Sander J; Lips, Esther H; Vrancken Peeters, Marie-Jeanne T; Kok, Niels F; Wiersma, Terry; Esserman, Laura; van 't Veer, Laura J; Linn, Sabine C; Siesling, Sabine; Sonke, Gabe S
Journal:
JNCI cancer spectrum
Issue:
Volume 5:Issue 3(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data. Issue 16 (December 2015)

Authors:
Meulendijks, Didier; Henricks, Linda M; Sonke, Gabe S; Deenen, Maarten J; Froehlich, Tanja K; Amstutz, Ursula; Largiadèr, Carlo R; Jennings, Barbara A; Marinaki, Anthony M; Sanderson, Jeremy D; Kleibl, Zdenek; Kleiblova, Petra; Schwab, Matthias; Zanger, Ulrich M; Palles, Claire; Tomlinson, Ian; G...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 16(2015)
Page Start:
1639
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2021)

Authors:
Banerjee, Susana; Moore, Kathleen N; Colombo, Nicoletta; Scambia, Giovanni; Kim, Byoung-Gie; Oaknin, Ana; Friedlander, Michael; Lisyanskaya, Alla; Floquet, Anne; Leary, Alexandra; Sonke, Gabe S; Gourley, Charlie; Oza, Amit; González-Martín, Antonio; Aghajanian, Carol; Bradley, William H; Holmes, ...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 12(2021)
Page Start:
1721
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial. Issue 12 (December 2018)

Authors:
van Ramshorst, Mette S; van der Voort, Anna; van Werkhoven, Erik D; Mandjes, Ingrid A; Kemper, Inge; Dezentjé, Vincent O; Oving, Irma M; Honkoop, Aafke H; Tick, Lidwine W; van de Wouw, Agnes J; Mandigers, Caroline M; van Warmerdam, Laurence J; Wesseling, Jelle; Vrancken Peeters, Marie-Jeanne T; L...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 12(2018)
Page Start:
1630
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗